USD10
MIST Shares
About Milestone PharmaceuticalsMilestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
USD10
MIST Shares
About Milestone PharmaceuticalsMilestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Stats
TRADING WINDOW
Open
CLOSES AT
8:00 PM GMT+0
MARKET CAP
$240.63M
OPEN PRICE
$2.09
LOW (1Y)
$0.88
HIGH (1Y)
$3.06
LOW (24H)
$1.98
HIGH (24H)
$2.10
VOLUME (24H)
$1.36M
0.87%
Price history
Time | Price | Change |
|---|---|---|
Today | $2.09 | |
1 Day | $2.01 | |
1 Week | $2.00 | |
1 Month | $1.41 | |
1 Year | $1.01 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
